Possible genotoxic modes of action for naphthalene

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 2 SUPLL, 2008, Pages 43-50

  Brusick, David ^h   Small, Mitchell S ^a,b   Cavalieri, Ercole L ^c   Chakravarti, Dhrubajyoti ^c   Ding, Xinxin ^d,e   Longfellow, David G ^f   Nakamura, Jun ^g   Rogan, Eleanor C ^c   Swenberg, James A ^g  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d WADSWORTH CENTER   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

^f Capital Hilton Hotel   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h NONE

Author keywords

1,2 Naphthoquinone; Biomarkers; Cancer; Carcinogenicity; Depurinating adducts; DNA adducts; Genotoxicity; Mechanism of action; Metabolism; Mode of action; Mutagenicity; Naphthalene; Stable adducts

Indexed keywords

DNA; NAPHTHALENE;

ARTICLE; CANCER RISK; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT TUMOR; RISK ASSESSMENT; SCIENTIFIC LITERATURE;

EID: 44649167248     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.12.002     Document Type: Article

References (22)

1. Belous A.R., Hachey D.L., Dawling S., Roodi N., and Parl F.F. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res. 67 (2007) 812-817
2. Belzer R.B., Bus J.S., Cavalieri E.L., Lewis S.C., North D.W., and Pleus R.C. Naphthalene state of the science symposium: objectives, organization, structure, and charge. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S1-S5
3. Bogen T.K., Benson J.M., Clewell H.J., Dahl A.R., Krishnan K., Morris J.B., Omiencinski C.J., and Yost G.S. Napthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S27-S36
4. Brusick D.J. A critical assessment of the genetic toxicity of naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S37-S42
5. Casale G.P., Singhal M., Bhattacharya S., RamaNathan R., Roberts K.P., Barbacci D.C., Zhao J., Jankowiak R., Gross M.L., Cavalieri E.L., Small G.J., Rennard S.I., Mumford J.L., and Shen M. Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol. 14 (2001) 192-201
6. Cavalieri, E.L., in preparation. From aromatic hydrocarbons to estrogens and then back to benzene and naphthalene, Naphthalene State of the Science Symposium, October 9-12, 2006 (http://www.naphthalenesymposium.org/Cavalieri2.pdf).
7. Cavalieri E.L., and Rogan E.G. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann. N.Y. Acad. Sci. 1089 (2006) 230-286
8. Chakravarti D., Mailander P.C., Cavalieri E.L., and Rogan E.G. Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia. Mutat. Res. 456 (2000) 17-32
9. Chakravarti, D., Venugopal, D., Mailander, P.C., Meza, J.L., Higginbotham, S., Cavalieri, E.L., Rogan, E.G., in press. The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin. Mutat. Res.
10. Chakravarti D., Mailander P.C., Li K.-M., Higginbotham S., Zhang H.L., Gross M.L., Meza J.L., Cavalieri E.L., and Rogan E.G. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20 (2001) 7945-7953
11. Flowers-Geary L., Bleczinski W., Harvey R.G., and Penning T.M. Cytotoxicity and mutagenicity of polycyclic aromatic hydrocarbon o-quinones produced by dihydrodiol dehydrogenase. Chem.-Biol. Interact. 99 (1996) 55-72
12. Gaikwad, N.W., Muti, P., Meza, J.L., Yang, L., Pruthi, S., Ingle, J., Rogan, E.G., Cavalieri, E.L., in press. The molecular etiology of breast cancer: evidence from biomarkers of risk. Int. J. Cancer.
13. Griego F.Y., Bogen K.T., Price P.S., and Weed D.L. Exposure, epidemiology and human cancer incidence of naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S22-S26
14. International Agency for Research on Cancer (IARC). 2002. Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 82. IARC, Lyon, France.
15. Markushin Y., Gaikwad N., Zhang H., Kapke P., Rogan E.G., Cavalieri E.L., Trock B.J., Pavlovich C., and Jankowiak R. Potential biomarker for early risk assessment of prostate cancer. The Prostate 66 14 (2006) 1565-1571
16. North D.W., Abdo K.M., Benson J.M., Dahl A.R., Morris J.B., Renne R., and Witschi H. A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S6-S14
17. Rogan E.G., RamaKrishna N.V., Higginbotham S., Cavalieri E.L., Jeong H., Jankowiak R., and Small G.J. Identification and quantitation of 7-(benzo[a]pyren-6-yl)guanine in the urine and feces of rats treated with benzo[a]pyrene. Chem. Res. Toxicol. 3 (1990) 441-444
18. Saeed M., Higginbotham S., Rogan E.G., and Cavalieri E.L. Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene. Chem.-Biol. Interact. 165 (2007) 175-188
19. Schreiner C.A. Genetic toxicity of naphthalene: a review. J. Toxicol. Environ. Health B, Crit. Rev. 6 2 (2003) 161-183
20. Todorovic R., Devanesan P., Higginbotham S., Zhao J., Gross M.L., Rogan E.G., and Cavalieri E.L. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. Carcinogenesis 22 (2001) 905-911
21. US Environmental Protection Agency (EPA). 2004a. Toxicological Review of Naphthalene, in Support of Summary Information on the Integrated Risk Information System (IRIS). US Environmental Protection Agency, Office of Research and Development, NCEA-S-1707, External Review Draft. Available at: http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=434727.
22. US Environmental Protection Agency (EPA). 2004b. Summary Review of Health Effects Associated with Naphthalene: Health Issue Assessment. EPA/600/8-87/055F (NTIS PB88172374). Available at: http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=434728.